Pharmacy-led support to help patients keep taking medicines after hospital discharge
Tests pharmacy-led help with medicine access in adults with chronic illness leaving hospital.
Key facts
- Who runs it
- University of Tennessee
- Where
- Knoxville and Memphis, United StatesSee the 2 sites
- Trial code
- Registry title
- Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- Status
- Recruiting
- People taking part
- 388 people, planned
- Started
- 6 Apr 2024
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Med AAAction intervention
- Record updated
- 29 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in hospital who have Medicaid or no health insurance and have several long-term conditions. It tests help with getting and taking medicines after leaving hospital.
- Age
- 21 years or older.
- Sex
- Men and women can join.
- Disease stage
- At least 2 of these long-term conditions during the hospital stay: diabetes, high blood pressure, high cholesterol, coronary artery disease, heart failure, chronic lung disease, chronic kidney disease, irregular heartbeat, stroke, or depression and anxiety. Using blood thinners is also listed.
- Earlier treatment
- People must be taking or be prescribed at least 2 long-term medicines for these conditions. They must be getting these medicines from the hospital pharmacy.
Main reasons for not taking part
- Both Medicare and Medicaid coverage
- Main reason for the hospital stay is cancer, pregnancy, or surgery for an acute problem
- Active psychosis, substance abuse, or suicidal thoughts during the stay
- Planned discharge to somewhere other than home
- Already in a pharmacy discharge program
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Medicaid or uninsured inpatients
- 21 years or older
- ≥2 of the complex chronic conditions during index admission or prescribed/using ≥2 chronic medications for these conditions
- Patients receiving chronic disease medications from the hospital pharmacy
- Patients will be eligible if they have multiple complex chronic conditions including diabetes, hypertension, high cholesterol, coronary artery disease, congestive heart failure, chronic lung disease, chronic kidney disease, arrhythmia, stroke, psychiatric disorders including depression and anxiety, or who are prescribed or using anticoagulants
Who cannot take part
- If the primary reason for the index admission is related to cancer, pregnancy, or a surgical procedure for an acute problem
- Medicare and Medicaid dual eligible patients
- If patients have diagnoses of active psychosis, substance abuse, or suicidal ideation during the index admission
- If the planned discharge location is not home
- If patients are part of an existing pharmacy discharge program
Where in United States
- University of Tennessee Medical CenterKnoxville, United StatesContact: Shauntá M ChamberlinNot yet recruiting
- University of Tennessee Health Science Center/Regional One HealthMemphis, United StatesContact: Kay Ryan, PharmDTaking people
About the trial
What the trial wants to find out
Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of readmissions and costs among these patients. Major patient-reported barriers to essential medication use after hospital discharge among low-income individuals are related to social determinants of health (SDOH) and include: 1) financial barriers , 2) transportation barriers, and 3) system-level barriers. Although, medication therapy management services are important during care transitions, these services have not proven effective in improving medication adherence after hospital discharge, highlighting a critical need for innovative interventions. The Medication Affordability, Accessibility, and Availability in Care Transitions (Med AAAction) Study will test the effectiveness of a pharmacy-led care transitions intervention versus usual care through a pragmatic randomized controlled trial of 388 Medicaid and uninsured hospital in-patients with MCC from three large healthcare systems in Tennessee. The intervention will involve: 1) medications with zero copay, 2) bedside delivery then home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up. We will examine the impact of the intervention during 12 months on 1) medication adherence (primary outcome) and 2) rapid primary care follow-up, 30-day readmissions, hospitalizations and emergency department visits, and costs. We will conduct key informant interviews to understand patient experience with the acre received during and after care transitions. By examining effectiveness of the intervention on outcomes including medication adherence, health care utilization, costs, and patient experience, this study will provide valuable results to health systems, payers, and policymakers to assist in future implementation and sustainability of the intervention for socioeconomically disadvantaged populations.
The 2 groups in the trial
- Med AAAction interventionExisting treatment, for comparison
The Med AAAction intervention will include the following components: 1) medications with zero copay, 2) bedside delivery and subsequent home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up after hospital discharge. The intervention will be provided for one-year.
- Usual care InterventionPlacebo, for comparison
As part of the usual care, the participating hospitals provide medication reconciliation services before hospital discharge. Usual care may also include MTM services for patients discharged on specialty medications or Medicare beneficiaries. Patients in both groups will receive financial incentives for completing their baseline survey ($15), and 3-month ($15), 6-month ($15), and 12-month ($25) follow-up visits.
Treatment: Med AAAction intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
- Plain-language title
- Pharmacy-led support to help patients keep taking medicines after hospital dischargeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 29 January 2026